Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Drug Therapy

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications

Drug Dosing: Geriatric Patients

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...

Dosage Regimens: Partial Pharmacokinetic Parameters

Dosage Regimens: Partial Pharmacokinetic Parameters

It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...

Dosage Regimen: Individualization

Dosage Regimen: Individualization

Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...

Dosage Regimens: Designs and Approaches

Dosage Regimens: Designs and Approaches

Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...

Drug Dosing: Obese Patients

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Efficacy of blended digital and face-to-face psychotherapy compared to enhanced psychotherapy for patients with Somatic Symptom Disorder (iSOMA+): study protocol for a multicenter randomized controlled pragmatic trial.

Trials·2026

Same author

Careless responding in ambulatory assessment: Comparing individuals with and without chronic pain.

Psychological assessment·2026

Same author

Assessing Chronic Pain Processes Longitudinally: Psychometric Evaluation of the German 'Assessing Chronic Pain Processes' (ProCEss) Item Set.

European journal of pain (London, England)·2026

Same author

Measuring Moral Injury Outcome and Distress in High-Risk Populations in Germany: A Validation Study.

Assessment·2026

Same author

High sensitivity, low specificity: Validation and diagnostic accuracy study of the PCL-5 in an Arabic-speaking treatment-seeking sample.

Journal of anxiety disorders·2026

Same author

Emotion regulation variability and flexibility in daily life show distinct associations with well-being, age, and executive functions.

Scientific reports·2026

Search research articles

Related Experiment Video

Updated: May 15, 2026

Using Continuous Data Tracking Technology to Study Exercise Adherence in Pulmonary Rehabilitation

Using Continuous Data Tracking Technology to Study Exercise Adherence in Pulmonary Rehabilitation

Published on: November 8, 2013

Medication adherence in the general population.

Julia A Glombiewski¹, Yvonne Nestoriuc, Winfried Rief

¹University of Marburg, Department of Clinical Psychology and Psychotherapy, Marburg, Germany. glombiew@staff.uni-marburg.de

|December 29, 2012

Summary

Medication nonadherence is common in the general population, with at least 33% of Germans repeatedly failing to follow treatment recommendations. This highlights the need for targeted public health initiatives to improve medication adherence.

More Related Videos

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

Related Experiment Videos

Last Updated: May 15, 2026

Using Continuous Data Tracking Technology to Study Exercise Adherence in Pulmonary Rehabilitation

Using Continuous Data Tracking Technology to Study Exercise Adherence in Pulmonary Rehabilitation

Published on: November 8, 2013

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

Area of Science:

Behavioral Science
Public Health
Pharmacology

Background:

Medication adherence is crucial for chronic conditions but often low in specific populations.
Understanding general population adherence rates is essential for setting realistic expectations and planning interventions.
Previous research has focused on specific patient groups, necessitating broader data on medication nonadherence.

Purpose of the Study:

To collect normative data on medication nonadherence within the general population.
To establish baseline rates of adherence and nonadherence across diverse demographics.
To inform public health strategies and clinical practice regarding medication-taking behaviors.

Main Methods:

A representative sample of 2,512 individuals from the German population was assessed.
Medication adherence was measured using the Rief Adherence Index.
Data on current medication intake and experienced side effects were also collected.

Main Results:

At least 33% of Germans repeatedly fail to adhere to pharmacological treatment recommendations.
Only 25% of the general population describe themselves as fully adherent to medications.
Nonadherence was more prevalent in younger individuals with higher socioeconomic status on short-term medications.
Experience with medication side effects was the strongest predictor of nonadherence.

Conclusions:

Medication nonadherence is a widespread issue in the general population, not limited to specific patient groups.
Achieving high medication adherence requires proactive efforts from healthcare providers and public health initiatives.
Nonadherence should be viewed as a general behavioral pattern rather than solely a drug-specific problem.